Company Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Pharmaceuticals

Market Closed - Nyse 04:00:00 2024-04-05 pm EDT 5-day change 1st Jan Change
1.1 USD +0.92% Intraday chart for Societal CDMO, Inc. 0.00% +213.84%

Business Summary

Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus in the area of small molecules. It is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company's key products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR and Donnatal liquids and tablets. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms, with specialization in modified release technologies and facilities to handle potent compounds and controlled substances.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 110,550,922 67,430,570 ( 61.00 %) 0 61.00 %

Company contact information

Societal CDMO, Inc.

1 East Uwchlan Avenue Suite 112

19341, Exton

+770 534 8239

http://www.societalcdmo.com
address Societal CDMO, Inc.(SCTL)
  1. Stock Market
  2. Equities
  3. SCTL Stock
  4. Company Societal CDMO, Inc.